BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25554238)

  • 1. Cardiac channelopathies in pediatric patients - 7-years single center experience.
    Illikova V; Hlivak P; Hatala R
    J Electrocardiol; 2015; 48(2):150-6. PubMed ID: 25554238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic and therapeutic aspects of loss-of-function cardiac sodium channelopathies in children.
    Chockalingam P; Clur SA; Breur JM; Kriebel T; Paul T; Rammeloo LA; Wilde AA; Blom NA
    Heart Rhythm; 2012 Dec; 9(12):1986-92. PubMed ID: 22885917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era.
    Aziz PF; Tanel RE; Zelster IJ; Pass RH; Wieand TS; Vetter VL; Vogel RL; Shah MJ
    Heart Rhythm; 2010 Jun; 7(6):781-5. PubMed ID: 20197117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.
    Pott C; Dechering DG; Reinke F; Muszynski A; Zellerhoff S; Bittner A; Köbe J; Wasmer K; Schulze-Bahr E; Mönnig G; Kotthoff S; Eckardt L
    Europace; 2011 Jun; 13(6):897-901. PubMed ID: 21292648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical ST segment elevation and ventricular fibrillation without structural heart disease: a new electrocardiographic presentation of a channelopathy?
    Lebreiro A; Sousa A; Silva A; Campos J; Maciel MJ
    Cardiology; 2010; 115(3):232-5. PubMed ID: 20299797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Focus on Pharmacological Management of Catecholaminergic Polymorphic Ventricular Tachycardia.
    Claudio B; Alice M; Daniel S
    Mini Rev Med Chem; 2018; 18(6):476-482. PubMed ID: 28685702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Asymptomatic channelopathies : Risk stratification and primary prophylaxis].
    Aweimer A; Mügge A; Akin I; El-Battrawy I
    Herzschrittmacherther Elektrophysiol; 2023 Jun; 34(2):101-108. PubMed ID: 37103573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Channelopathies That Lead to Sudden Cardiac Death: Clinical and Genetic Aspects.
    Skinner JR; Winbo A; Abrams D; Vohra J; Wilde AA
    Heart Lung Circ; 2019 Jan; 28(1):22-30. PubMed ID: 30389366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postmortem genetic testing in sudden cardiac death due to ion channelopathies].
    Guan DW; Zhao R
    Fa Yi Xue Za Zhi; 2010 Apr; 26(2):120-7. PubMed ID: 20653139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited ion channel diseases: a brief review.
    Lieve KV; Wilde AA
    Europace; 2015 Oct; 17 Suppl 2():ii1-6. PubMed ID: 26842110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital long QT 3 in the pediatric population.
    Blaufox AD; Tristani-Firouzi M; Seslar S; Sanatani S; Trivedi B; Fischbach P; Paul T; Young ML; Tisma-Dupanovic S; Silva J; Cuneo B; Fournier A; Singh H; Tanel RE; Etheridge SP
    Am J Cardiol; 2012 May; 109(10):1459-65. PubMed ID: 22360817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac channelopathies and sudden infant death syndrome.
    Tfelt-Hansen J; Winkel BG; Grunnet M; Jespersen T
    Cardiology; 2011; 119(1):21-33. PubMed ID: 21778721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Channelopathies: Recognition, Treatment, Management.
    Hickey KT; Elzomor A
    AACN Adv Crit Care; 2018; 29(1):43-57. PubMed ID: 29496713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of channelopathies and cardiomyopathies in Hong Kong Chinese patients: a 10-year regional laboratory experience.
    Mak CM; Chen SP; Mok NS; Siu WK; Lee HH; Ching CK; Tsui PT; Fong NC; Yuen YP; Poon WT; Law CY; Chong YK; Chan YW; Yung TC; Fan KY; Lam CW
    Hong Kong Med J; 2018 Aug; 24(4):340-349. PubMed ID: 29497013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of syncope as a presenting symptom in channelopathies diagnosed in childhood. Can the multivariable EGSYS score unmask these children?
    Környei L; Szabó A; Róth G; Kardos A; Fogarasi A
    Eur J Pediatr; 2021 May; 180(5):1553-1559. PubMed ID: 33447893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of ventricular tachycardia storms not terminated by implantable cardioverter defibrillators shocks in patients with CASQ2 associated catecholaminergic polymorphic ventricular tachycardia.
    Marai I; Khoury A; Suleiman M; Gepstein L; Blich M; Lorber A; Boulos M
    Am J Cardiol; 2012 Jul; 110(1):72-6. PubMed ID: 22481011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Channelopathies as Causes of Sudden Cardiac Death.
    Schwartz PJ; Ackerman MJ; Wilde AAM
    Card Electrophysiol Clin; 2017 Dec; 9(4):537-549. PubMed ID: 29173400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into channelopathies: progress in clinical practice and research.
    Matusik PT
    J Electrocardiol; 2017; 50(4):534-535. PubMed ID: 28238439
    [No Abstract]   [Full Text] [Related]  

  • 19. Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders.
    Bos JM; Bos KM; Johnson JN; Moir C; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):705-11. PubMed ID: 23728945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for inheritable cardiac channelopathies.
    Szepesváry E; Kaski JP
    Br J Hosp Med (Lond); 2016 May; 77(5):294-302. PubMed ID: 27166108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.